|
1
|
Messina M: A brief historical overview of
the past two decades of soy and isoflavone research. J Nutr.
140:S1350–S1354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kao TH and Chen BH: Functional components
in soybean cake and their effects on antioxidant activity. J Agric
Food Chem. 54:7544–7555. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kao TH, Huang RFS and Chen BH:
Antiproliferation of hepatoma cell and progression of cell cycle as
affected by isoflavone extracts from soybean cake. Int J Mol Sci.
8:1095–1110. 2007. View
Article : Google Scholar
|
|
4
|
Kao TH, Wu WM, Hung CF, Wu WB and Chen BH:
Anti-inflammatory effects of isoflavone powder produced from
soybean cake. J Agric Food Chem. 55:11068–11079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dalais FS, Ebeling PR, Kotsopoulos D,
McGrath BP and Teede HJ: The effects of soy protein containing
isoflavones on lipids and indices of bone resorption in
postmenopausal women. Clin Endocrinol (Oxf). 58:704–709. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Migliaccio S and Anderson JJ: Isoflavones
and skeletal health: are these molecules ready for clinical
application? Osteoporos Int. 14:361–368. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Farina HG, Pomies M, Alonso DF and Gomez
DE: Antitumor and antiangiogenic activity of soy isoflavone
genistein in mouse models of melanoma and breast cancer. Oncol Rep.
16:885–891. 2006.PubMed/NCBI
|
|
8
|
Wada K, Nakamura K, Tamai Y, et al: Soy
isoflavone intake and breast cancer risk in Japan: From the
Takayama study. Int J Cancer. Feb 6–2013.(Epub ahead of print).
View Article : Google Scholar
|
|
9
|
Boucher BA, Cotterchio M, Anderson LN,
Kreiger N, Kirsh VA and Thompson LU: Use of isoflavone supplements
is associated with reduced postmenopausal breast cancer risk. Int J
Cancer. 132:1439–1450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang YF, Kang HB, Li BL and Zhang RM:
Positive effects of soy isoflavone food on survival of breast
cancer patients in China. Asian Pac J Cancer Prev. 13:479–482.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Satoh H, Nishikawa K, Suzuki K, et al:
Genistein, a soy isoflavone, enhances necrotic-like cell death in a
breast cancer cell treated with a chemotherapeutic agent. Res
Commun Mol Pathol Pharmacol. 113–114:149–158. 2003.PubMed/NCBI
|
|
12
|
Xie Q, Chen ML, Qin Y, et al: Isoflavone
consumption and risk of breast cancer: a dose-response
meta-analysis of observational studies. Asia Pac J Clin Nutr.
22:118–127. 2013.PubMed/NCBI
|
|
13
|
Akaza H, Miyanaga N, Takashima N, et al:
Is daidzein non-metabolizer a high risk for prostate cancer? A
case-controlled study of serum soybean isoflavone concentration.
Jpn J Clin Oncol. 32:296–300. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kurahashi N, Iwasaki M, Sasazuki S, Otani
T, Inoue M and Tsugane S: Soy product and isoflavone consumption in
relation to prostate cancer in Japanese men. Cancer Epidemiol
Biomarkers Prev. 16:538–545. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Perabo FG, Von Low EC, Ellinger J, von
Rucker A, Muller SC and Bastian PJ: Soy isoflavone genistein in
prevention and treatment of prostate cancer. Prostate Cancer
Prostatic Dis. 11:6–12. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sugiyama Y, Masumori N, Fukuta F, et al:
Influence of isoflavone intake and equol-producing intestinal flora
on prostate cancer risk. Asian Pac J Cancer Prev. 14:1–4. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
File SE, Jarrett N, Fluck E, Duffy R,
Casey K and Wiseman H: Eating soya improves human memory.
Psychopharmacology (Berl). 157:430–436. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bone HG, Greenspan SL, McKeever C, et al:
Alendronate and estrogen effects in postmenopausal women with low
bone mineral density. Alendronate/Estrogen Study Group. J Clin
Endocrinol Metab. 85:720–726. 2000.PubMed/NCBI
|
|
19
|
Gallagher JC: The pathogenesis of
osteoporosis. Bone Miner. 9:215–227. 1990. View Article : Google Scholar
|
|
20
|
Wei P, Liu M, Chen Y and Chen DC:
Systematic review of soy isoflavone supplements on osteoporosis in
women. Asian Pac J Trop Med. 5:243–248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Verhaeghe J, van Bree R, Van Herck E, et
al: Effects of recombinant human growth hormone and insulin-like
growth factor-I, with or without 17 beta-estradiol, on bone and
mineral homeostasis of aged ovariectomized rats. J Bone Miner Res.
11:1723–1735. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nielsen TF, Ravn P, Bagger YZ, Warming L
and Christiansen C: Pulsed estrogen therapy in prevention of
postmenopausal osteoporosis. A 2-year randomized, double blind,
placebo-controlled study. Osteoporos Int. 15:168–174.
2004.PubMed/NCBI
|
|
23
|
Seeman E: Estrogen, androgen, and the
pathogenesis of bone fragility in women and men. Curr Osteoporos
Rep. 2:90–96. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Celec P, Ostatnikova D, Caganova M, et al:
Endocrine and cognitive effects of short-time soybean consumption
in women. Gynecol Obstet Invest. 59:62–66. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kritz-Silverstein D, Von Muhlen D,
Barrett-Connor E and Bressel MA: Isoflavones and cognitive function
in older women: the SOy and Postmenopausal Health In Aging (SOPHIA)
Study. Menopause. 10:196–202. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lephart ED, West TW, Weber KS, et al:
Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol
Teratol. 24:5–16. 2002. View Article : Google Scholar
|
|
27
|
Lund TD, West TW, Tian LY, et al: Visual
spatial memory is enhanced in female rats (but inhibited in males)
by dietary soy phytoestrogens. BMC Neurosci. 2:202001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee YB, Lee HJ, Won MH, et al: Soy
isoflavones improve spatial delayed matching-to-place performance
and reduce cholinergic neuron loss in elderly male rats. J Nutr.
134:1827–1831. 2004.PubMed/NCBI
|
|
29
|
Bang OY, Hong HS, Kim DH, et al:
Neuroprotective effect of genistein against beta amyloid-induced
neurotoxicity. Neurobiol Dis. 16:21–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Behl C: Alzheimer’s disease and oxidative
stress: implications for novel therapeutic approaches. Prog
Neurobiol. 57:301–323. 1999.
|
|
31
|
Holscher C: Possible causes of Alzheimer’s
disease: amyloid fragments, free radicals, and calcium homeostasis.
Neurobiol Dis. 5:129–141. 1998.
|
|
32
|
Morris JC: Dementia update 2003. Alzheimer
Dis Assoc Disord. 17:245–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ramassamy C, Averill D, Beffert U, et al:
Oxidative insults are associated with apolipoprotein E genotype in
Alzheimer’s disease brain. Neurobiol Dis. 7:23–37. 2000.PubMed/NCBI
|
|
34
|
Zeng H, Chen Q and Zhao B: Genistein
ameliorates beta-amyloid peptide (25–35) -induced hippocampal
neuronal apoptosis. Free Radic Biol Med. 36:180–188.
2004.PubMed/NCBI
|
|
35
|
Pan Y, Anthony M and Clarkson TB: Effect
of estradiol and soy phytoestrogens on choline acetyltransferase
and nerve growth factor mRNAs in the frontal cortex and hippocampus
of female rats. Proc Soc Exp Biol Med. 221:118–125. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xi YD, Li XY, Ding J, et al: Soy
isoflavone alleviates Aβ1–42-induced impairment of learning and
memory ability through the regulation of RAGE/LRP-1 in neuronal and
vascular tissue. Curr Neurovasc Res. 10:144–156. 2013.
|
|
37
|
Tikkanen MJ and Adlercreutz H: Dietary
soy-derived isoflavone phytoestrogens. Could they have a role in
coronary heart disease prevention? Biochem Pharmacol. 60:1–5. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Beavers DP, Beavers KM, Miller M, Stamey J
and Messina MJ: Exposure to isoflavone-containing soy products and
endothelial function: a Bayesian meta-analysis of randomized
controlled trials. Nutr Metab Cardiovasc Dis. 22:182–191. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamakoshi J, Piskula MK, Izumi T, et al:
Isoflavone aglycone-rich extract without soy protein attenuates
atherosclerosis development in cholesterol-fed rabbits. J Nutr.
130:1887–1893. 2000.PubMed/NCBI
|
|
40
|
Chan YH, Lau KK, Yiu KH, et al: Reduction
of C-reactive protein with isoflavone supplement reverses
endothelial dysfunction in patients with ischaemic stroke. Eur
Heart J. 29:2800–2807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gilbert ER and Liu D: Anti-diabetic
functions of soy isoflavone genistein: mechanisms underlying its
effects on pancreatic β-cell function. Food Funct. 4:200–212.
2013.PubMed/NCBI
|
|
42
|
Behloul N and Wu G: Genistein: a promising
therapeutic agent for obesity and diabetes treatment. Eur J
Pharmacol. 698:31–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Valsecchi AE, Franchi S, Panerai AE, Rossi
A, Sacerdote P and Colleoni M: The soy isoflavone genistein
reverses oxidative and inflammatory state, neuropathic pain,
neurotrophic and vasculature deficits in diabetes mouse model. Eur
J Pharmacol. 650:694–702. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chiang HS, Wu WB, Fang JY, et al:
UVB-protective effects of isoflavone extracts from soybean cake in
human keratinocytes. Int J Mol Sci. 8:651–661. 2007. View Article : Google Scholar
|
|
45
|
Chiu TM, Huang CC, Lin TJ, Fang JY, Wu NL
and Hung CF: In vitro and in vivo anti-photoaging effects of an
isoflavone extract from soybean cake. J Ethnopharmacol.
126:108–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Assefa Z, Van Laethem A, Garmyn M and
Agostinis P: Ultraviolet radiation-induced apoptosis in
keratinocytes: on the role of cytosolic factors. Biochim Biophys
Acta. 1755:90–106. 2005.PubMed/NCBI
|
|
47
|
Portman MA: Kawasaki disease and soy:
potential role for isoflavone interaction with Fcgγ receptors.
Pediatr Res. 73:130–134. 2013.PubMed/NCBI
|
|
48
|
Safe S: Endocrine disruptors and human
health: is there a problem. Toxicology. 205:3–10. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Paganetto G, Campi F, Varani K, Piffanelli
A, Giovannini G and Borea PA: Endocrine-disrupting agents on
healthy human tissues. Pharmacol Toxicol. 86:24–29. 2000.
View Article : Google Scholar
|
|
50
|
Wuttke W, Jarry H, Becker T, et al:
Phytoestrogens: endocrine disrupters or replacement for hormone
replacement therapy? Maturitas. 44(Suppl 1): S9–S20. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Helferich WG, Andrade JE and Hoagland MS:
Phytoestrogens and breast cancer: a complex story.
Inflammopharmacology. 16:219–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen A and Rogan WJ: Isoflavones in soy
infant formula: a review of evidence for endocrine and other
activity in infants. Annu Rev Nutr. 24:33–54. 2004. View Article : Google Scholar : PubMed/NCBI
|
